Lung neuroendocrine tumors are a heterogeneous subtype of pulmonary cancers
representing approximately 20% of all lung cancers, including small-cell lung cancer …

Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare and highly aggressive
type of lung cancer, with a complex biology that shares similarities with both small-cell lung …

Background Large cell neuroendocrine carcinoma (LCNEC) accounts for approximately 3%
of lung cancers. Pathologic classification and optimal therapies are debated. We report the …

BACKGROUND: There is controversy regarding palliative chemotherapy for large cell
neuroendocrine carcinoma (LCNEC). We evaluated whether advanced LCNEC should be …

Background Large cell neuroendocrine carcinoma (LCNEC) is a rare, aggressive cancer
with a dismal prognosis. The majority of cases occur in the lung and the gastrointestinal …

Recent advances in the treatment of non-small cell lung cancer (NSCLC) with new agents
require accurate histological subtyping at diagnosis to avoid the higher risk of an adverse …

Large cell neuroendocrine carcinoma (LCNEC) of the lung is categorized as a variant of
large cell carcinomas, and LCNEC tumors display biological behaviors resembling those of …

Lung large cell neuroendocrine carcinoma (L-LCNEC) is a rare, aggressive, and difficult-to-
treat tumor. It is classified as a neuroendocrine subtype of large cell lung carcinoma (LCLC) …

Background Large cell neuroendocrine carcinoma (LCNEC) of the lung is a rare, aggressive
cancer most commonly found in the lungs but not exclusively, with a worse prognosis than …

The current classification of pulmonary neuroendocrine tumours includes four subtypes: low-
grade typical carcinoid tumour (TC), intermediate-grade atypical carcinoid tumour (AC), and …